Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 10 studies | 27% ± 8% | |
macrophage | 7 studies | 25% ± 6% | |
goblet cell | 6 studies | 23% ± 6% | |
platelet | 6 studies | 29% ± 11% | |
basal cell | 6 studies | 27% ± 12% | |
hepatocyte | 5 studies | 53% ± 26% | |
cholangiocyte | 4 studies | 66% ± 21% | |
abnormal cell | 4 studies | 17% ± 1% | |
type I pneumocyte | 4 studies | 21% ± 4% | |
alveolar macrophage | 4 studies | 35% ± 13% | |
non-classical monocyte | 3 studies | 25% ± 7% | |
megakaryocyte | 3 studies | 34% ± 13% | |
astrocyte | 3 studies | 32% ± 18% | |
club cell | 3 studies | 26% ± 5% | |
monocyte | 3 studies | 28% ± 12% |
Insufficient scRNA-seq data for expression of ABCC3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 16819.00 | 226 / 226 | 94% | 62.54 | 381 / 406 |
pancreas | 100% | 9393.56 | 327 / 328 | 93% | 92.43 | 165 / 178 |
stomach | 88% | 8843.74 | 316 / 359 | 94% | 52.91 | 270 / 286 |
lung | 99% | 3970.07 | 571 / 578 | 80% | 55.93 | 919 / 1155 |
kidney | 90% | 4993.62 | 80 / 89 | 86% | 62.46 | 772 / 901 |
thymus | 83% | 4941.93 | 544 / 653 | 75% | 30.33 | 455 / 605 |
intestine | 56% | 8183.27 | 537 / 966 | 98% | 58.50 | 514 / 527 |
bladder | 71% | 4892.86 | 15 / 21 | 76% | 38.10 | 381 / 504 |
adrenal gland | 100% | 36773.08 | 258 / 258 | 34% | 13.90 | 78 / 230 |
esophagus | 44% | 1783.84 | 637 / 1445 | 78% | 56.41 | 142 / 183 |
breast | 75% | 3681.70 | 343 / 459 | 38% | 9.56 | 427 / 1118 |
prostate | 91% | 6974.18 | 222 / 245 | 14% | 1.73 | 68 / 502 |
skin | 99% | 5551.76 | 1796 / 1809 | 4% | 0.71 | 19 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.54 | 1 / 1 |
spleen | 95% | 2755.80 | 230 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 72% | 2990.71 | 957 / 1335 | 0% | 0 | 0 / 0 |
adipose | 62% | 1333.59 | 752 / 1204 | 0% | 0 | 0 / 0 |
uterus | 21% | 396.52 | 35 / 170 | 40% | 15.23 | 183 / 459 |
lymph node | 0% | 0 | 0 / 0 | 38% | 4.90 | 11 / 29 |
ovary | 22% | 357.61 | 40 / 180 | 12% | 2.23 | 51 / 430 |
peripheral blood | 27% | 402.00 | 248 / 929 | 0% | 0 | 0 / 0 |
brain | 1% | 13.22 | 23 / 2642 | 25% | 9.71 | 175 / 705 |
tonsil | 0% | 0 | 0 / 0 | 16% | 2.86 | 7 / 45 |
heart | 6% | 100.53 | 53 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 11.09 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0006855 | Biological process | xenobiotic transmembrane transport |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0015779 | Biological process | glucuronoside transport |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0042908 | Biological process | xenobiotic transport |
GO_0071716 | Biological process | leukotriene transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0071714 | Molecular function | icosanoid transmembrane transporter activity |
GO_0140359 | Molecular function | ABC-type transporter activity |
GO_0043225 | Molecular function | ATPase-coupled inorganic anion transmembrane transporter activity |
GO_0015432 | Molecular function | ABC-type bile acid transporter activity |
GO_0008559 | Molecular function | ABC-type xenobiotic transporter activity |
GO_0015431 | Molecular function | ABC-type glutathione S-conjugate transporter activity |
GO_0042910 | Molecular function | xenobiotic transmembrane transporter activity |
GO_0005524 | Molecular function | ATP binding |
GO_0042626 | Molecular function | ATPase-coupled transmembrane transporter activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0015164 | Molecular function | glucuronoside transmembrane transporter activity |
Gene name | ABCC3 |
Protein name | ABCC3 protein ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3) ATP binding cassette subfamily C member 3 |
Synonyms | CMOAT2 MRP3 MLP2 |
Description | FUNCTION: ATP-dependent transporter of the ATP-binding cassette (ABC) family that binds and hydrolyzes ATP to enable active transport of various substrates including many drugs, toxicants and endogenous compound across cell membranes . Transports glucuronide conjugates such as bilirubin diglucuronide, estradiol-17-beta-o-glucuronide and GSH conjugates such as leukotriene C4 (LTC4) . Transports also various bile salts (taurocholate, glycocholate, taurochenodeoxycholate-3-sulfate, taurolithocholate- 3-sulfate) (By similarity). Does not contribute substantially to bile salt physiology but provides an alternative route for the export of bile acids and glucuronides from cholestatic hepatocytes (By similarity). May contribute to regulate the transport of organic compounds in testes across the blood-testis-barrier (Probable). Can confer resistance to various anticancer drugs, methotrexate, tenoposide and etoposide, by decreasing accumulation of these drugs in cells . . |
Accessions | ENST00000427699.5 [O15438-5] D6RAB7 Q2M3C9 O15438 ENST00000510633.5 ENST00000513745.1 ENST00000502426.5 [O15438-3] H0Y8T5 ENST00000513511.5 ENST00000515585.1 ENST00000515707.1 ENST00000505699.5 [O15438-2] D6RJE5 H0Y8Q6 Q86VN9 H0Y9T4 ENST00000285238.13 [O15438-1] |